1 hr ago | The Washington Post
St. Jude Looks to New Technologies to Bolster Sales Growth
St. Jude Medical Inc., maker of devices to treat heart conditions, is betting on new technologies this year to overcome weak demand for older medical products, Chief Executive Officer Daniel Starks said.
5 hrs ago | Philly.com
Man sentenced, 2d pleads guilty in S. Jersey child porn cases
Two Gloucester County men appeared in federal court in Camden today on child porn charges Friday, one to be sentenced for advertising it, the other to plead guilty to possession.
7 hrs ago | Stock Market Review
Edwards Lifesciences Reports Solid Fourth Quarter Results
Edwards Lifesciences Corporation , the global leader in the science of heart valves and hemodynamic monitoring, today reported net income for the quarter ended December 31, 2011 of $63.1 million, or $0.53 per diluted share, compared to net income of $64.8 million, or $0.54 per diluted share, for the same period in 2010.
11 hrs ago | Wall St. Cheat Sheet
Becton, Dickinson and Co. First Quarter Earnings Sneak Peek
S&P 500 component Becton, Dickinson and Co. will unveil its latest earnings on Tuesday, February 7, 2012.
15 hrs ago | The Tennessean
Mayor Karl Dean expands after-school programs
Mayor Karl Dean pushed for the after-school programs, which started in the 2009-2010 school year.
18 hrs ago | Journal Gazette
OrthoWorks to study specialty orthopedics hospital
At a glance A study released last year by the Business Research Center shows that in 2009, Kosciusko County's orthopedic cluster: * Provided 13,000 jobs, or 43 percent of the county's employment.
Democrats Want to Let FDA Block Devices Tied to Recalls
U.S. regulators should be able to block medical devices based on past products with safety issues, said House Democrats, citing injuries from transvaginal implants like those made by Johnson & Johnson and C.R. Bard Inc.
Feds drop fraud charges against former Stryker Biotech president
The federal government has dropped fraud charges against former Stryker Biotech president Mark Philip , Philip's lawyers announced, Thursday.
Hillenbrand reports 10% sales gain in 1Q
The process equipment group's revenue was up 68 percent to $86 million, with organic growth of 20 percent.
Boston Scientific Falls After Fourth-Quarter Profit Plunges
Shares of Boston Scientific Corp., the second-biggest cardiac-device maker, fell the most in almost two months after fourth-quarter earnings plummeted 55 percent.
The Cooper Companies Inc - Momentum
We are in the midst of a major overhaul in healthcare. In the coming years, millions more Americans will be receiving care and will need both providers of care as well as devices that make care more efficient and less costly.
Bard Tops in 4Q, Charges Crimp Net - Analyst Blog
Leading medical devices maker C. R. Bard 's adjusted earnings for fourth-quarter fiscal 2011 topped expectation but lofty charges dragged down its profits for the quarter.
Edwards Lifesciences Announces Promising Transcatheter Patient Data
Medgadget was profiled in The Arizona Republic , The Los Angeles Times , BMJ , Silicon Valley / San Jose Business Journal , and other publications.
Rancho's ThermoGenesis shakes up top team, to cut 8 jobs
Rancho Cordova-based medical equipment firm ThermoGenesis Corp., which has been working to reverse fiscal losses, is realigning top management and cutting eight positions.
Hologic (HOLX) Shares Given an "Equalweight" Rating by Barclays Capital (BCS) Analysts
Hologic 's stock had its "equalweight" rating reiterated by analysts at Barclays Capital in a research report issued to clients and investors on Tuesday.
Investment analysts at Citigroup raised their price target on shares of C.R. Bard to $95.00 in a note issued to investors on Wednesday.
Zimmer Holdings was downgraded by UBS AG from a "buy" rating to a "neutral" rating in a research note issued on Wednesday.
Energy Business Recap: Exxon's Fourth Quarter, Hess Insider Buying
Exxon Mobil's fourth quarter profits at the upstream unit, which produces oil and natural gas, are up 18% which have been helped by higher prices.
Device Makers Said to Double FDA Fees to Produce Faster Reviews
Medical device makers will double the fees they pay U.S. regulators to get their products reviewed over the next five years, to $595 million, in a deal designed to secure faster and more predictable evaluations, say two people with knowledge of the talks.
C. R. Bard Inc. Earnings: Increased Costs Strains Margins as Profit Drops
S&P 500 component C. R. Bard Inc. reported its results for the fourth quarter. C.R. Bard designs, makes, and sells diagnostic, medical, surgical, and patient care devices.
Also on Topix